RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cardiff Oncology Stock

Cardiff Oncology Employees 2025

Cardiff Oncology Employees

12

Ticker

CRDF

ISIN

US14147L1089

WKN

A2P4GU

In 2025, Cardiff Oncology employed 12 people, a 0% change from the 12 number of employees in the previous year.

Cardiff Oncology Aktienanalyse

What does Cardiff Oncology do?

Cardiff Oncology Inc. is a biopharmaceutical company that focuses on the development of new treatment options for cancer patients. The company was founded in 2006 and is based in San Diego, California. The history of Cardiff Oncology Inc. began with the development of ProLindac, an innovative drug for the treatment of advanced ovarian cancer. ProLindac was tested in phase II studies and showed promising results. However, in 2010, the project was discontinued due to financial reasons. Despite this setback, Cardiff Oncology has continued its search for new therapies against cancer. The company specializes in the development of drugs that specifically target and kill cancer cells or inhibit their growth. A major focus of Cardiff Oncology is the treatment of metastatic breast cancer. The company has developed a novel drug called OMG-003, which is currently in phase I studies. OMG-003 is an antibody-drug conjugate (ADC) that targets a specific target molecule on breast cancer cells. The goal of OMG-003 is to destroy the cancer cells without damaging healthy cells. In addition to the development of OMG-003, Cardiff Oncology is also working on other promising projects. Another drug called ONC201 is also in phase I studies. ONC201 is a small molecule based on a new therapeutic platform that specifically targets cancer cells. Cardiff Oncology's business model is based on advancing the research and development of cancer therapies and then selling them to licensees or partner companies. The company has filed a number of patents on its technologies and drugs and collaborates closely with universities and other research institutions. In terms of its organization, the company consists of a team of experienced scientists, doctors, and managers. Cardiff Oncology has a network of contractors and consultants who support the conduct of clinical trials and the development of new products. Overall, Cardiff Oncology has promising development projects in its pipeline. The company focuses on developing new and innovative therapies that have the potential to extend the lives of cancer patients and improve their quality of life. With a strong pipeline and experienced leadership, the company appears to be well-positioned for success in the future. Cardiff Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Cardiff Oncology's Employee Base

Cardiff Oncology's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Cardiff Oncology's operational capacity and future potential.

Year-to-Year Comparison

Assessing Cardiff Oncology's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Cardiff Oncology's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Cardiff Oncology’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Cardiff Oncology stock

How many employees does Cardiff Oncology have this year?

Cardiff Oncology has 12 undefined employees this year.

How many employees did Cardiff Oncology have compared to the previous year?

Compared to the previous year, Cardiff Oncology had 0% more employees.

What impact did the number of employees have on the company Cardiff Oncology?

The number of employees has a direct impact on the efficiency and productivity of Cardiff Oncology. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Cardiff Oncology?

The number of employees can also have an impact on investors of Cardiff Oncology, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Cardiff Oncology affect the company?

An increase in equity of Cardiff Oncology can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Cardiff Oncology's equity affect the company?

A reduction in equity of Cardiff Oncology can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Cardiff Oncology?

Some factors that can influence the equity of Cardiff Oncology include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Cardiff Oncology so important for investors?

The equity of Cardiff Oncology is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Cardiff Oncology influence the company?

The number of employees at Cardiff Oncology can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Cardiff Oncology evolved in recent years?

In recent years, the number of employees at Cardiff Oncology has changed by 0.

How many employees does Cardiff Oncology currently have?

Cardiff Oncology currently has 12 undefined employees.

Why is the number of employees important for investors of Cardiff Oncology?

The number of employees is important for investors of Cardiff Oncology as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Cardiff Oncology take to change the number of employees?

To change the number of employees, Cardiff Oncology can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Cardiff Oncology pay?

Over the past 12 months, Cardiff Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cardiff Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Cardiff Oncology?

The current dividend yield of Cardiff Oncology is .

When does Cardiff Oncology pay dividends?

Cardiff Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cardiff Oncology?

Cardiff Oncology paid dividends every year for the past 0 years.

What is the dividend of Cardiff Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cardiff Oncology located?

Cardiff Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cardiff Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cardiff Oncology from 7/15/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/15/2025.

When did Cardiff Oncology pay the last dividend?

The last dividend was paid out on 7/15/2025.

What was the dividend of Cardiff Oncology in the year 2024?

In the year 2024, Cardiff Oncology distributed 0 USD as dividends.

In which currency does Cardiff Oncology pay out the dividend?

The dividends of Cardiff Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cardiff Oncology

Our stock analysis for Cardiff Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardiff Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.